The consolidated evidence that SARS-CoV-2 is efficiently able to interplay with heparan sulfate proteoglycans on host cell surface for primary attachment before high-affinity interaction of RBD with ACE2, provides reasonable and reinforced support for the importance of heparin usage in COVID-19. In fact, the antiviral activity of heparin may ultimately complement its well-known anticoagulant and even anti-inflammatory properties, thus generating an additional (pleiotropic) effect—besides lowering the risk of thrombosis and counteracting hyperinflammation—that may favorably influence the clinical course of SARS-CoV-2 infection, especially in the most vulnerable subjects. Notably, nasal heparin sprays are undergoing clinical trials to evaluate their potential to mitigate SARS-CoV-2 infectivity,29 and thus aid other approaches to prevent COVID-19, including vaccination efforts.

The Benefits of Heparin Use in COVID-19: Pleiotropic Antiviral Activity beyond Anticoagulant and Anti-Inflammatory Properties

Lippi, Giuseppe
;
2023-01-01

Abstract

The consolidated evidence that SARS-CoV-2 is efficiently able to interplay with heparan sulfate proteoglycans on host cell surface for primary attachment before high-affinity interaction of RBD with ACE2, provides reasonable and reinforced support for the importance of heparin usage in COVID-19. In fact, the antiviral activity of heparin may ultimately complement its well-known anticoagulant and even anti-inflammatory properties, thus generating an additional (pleiotropic) effect—besides lowering the risk of thrombosis and counteracting hyperinflammation—that may favorably influence the clinical course of SARS-CoV-2 infection, especially in the most vulnerable subjects. Notably, nasal heparin sprays are undergoing clinical trials to evaluate their potential to mitigate SARS-CoV-2 infectivity,29 and thus aid other approaches to prevent COVID-19, including vaccination efforts.
Heparin, COVID-19, Anticoagulant, Anti-Inflammatory
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/1057816
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 8
social impact